Key facts
- Protera’s last known valuation is $29.4M (Mar 2023).
- It has raised $32.6M.
- Notable investors include SOSV, EIT Food, IndieBio, Sofinnova Partners, Bimbo Ventures — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Protera
- ·The full record, as it builds
Funding rounds
No funding rounds for Protera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Protera
Producer of protein-based food ingredients intended to design highly functional food ingredients faster and cheaper, and address ethical, environmental, and consumer health challenges with Artificial Intelligence (AI)-driven protein engineering. The company's agency streamlines protein design and development with a proprietary deep-learning algorithm to predict high-value protein products and enzymes with unprecedented speed, enabling customers to get healthy, safe foods made from ingredients that are produced responsibly and sustainably, predicting yields cost-effectively, and accelerating from discovery to market with robust IP and strategic partnerships.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Paris, France
- Founded
- 2015
- Employees
- 21
- Website
- proterabio.com/
- Ownership
- Privately Held (backing)
Protera doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Protera shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Protera in its N-PORT filings yet. We sweep new filings monthly.